Publications by authors named "Maria Klockare"

Claim this Profile
P
Phase I clinical trial of AXL1717 for treatment of relapsed malignant astrocytomas: analysis of dose and response.
Robert Aiken, Magnus Axelson, Johan Harmenberg, Maria Klockare, Olle Larsson

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II randomized study of the IGF-1R pathway modulator AXL1717 compared to docetaxel in patients with previously treated, locally advanced or metastatic non-small cell lung cancer.
Michael Bergqvist, Georg Holgersson, Igor Bondarenko, Elena Grechanaya, Alexey Maximovich, Maria Klockare

Acta Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally advanced, or metastatic non-small cell lung cancer.
Georg Holgersson, Stefan Bergström, Johan Harmenberg, Magnus Ringbom, Maria Klockare

Med Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between direct humidification and nebulization of the respiratory tract at mechanical ventilation: distribution of saline solution studied by gamma camera.
Maria Klockare, Ann Dufva, Anne-Marie Danielsson, Robert Hatherly, Stig Larsson

J Clin Nurs· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis